Simultaneous Daily Fecal Microbiota Transplantation Fails to Prevent Metronidazole-Induced Dysbiosis of Equine Gut Microbiota.

The research attempts to assess whether simultaneous fecal microbiota transplantation (FMT) can prevent the imbalance of gastrointestinal microbiota caused by metronidazole administration in horses. The results suggest that this method of prevention is ineffective and further improvements to the FMT protocol are necessary.

Research Context

• Antimicrobials, like metronidazole, can disrupt the balance of microbiota in the horse’s gut, causing a condition known as dysbiosis. This can lead to problems such as diarrhea and inflammation of the intestines.
• Fecal microbiota transplantation (FMT), a procedure that involves transferring the microbiota from a healthy donor’s feces to the recipient’s gut, is commonly used to treat dysbiosis. However, the effectiveness of FMT as a preventive measure against dysbiosis in horses being treated with antimicrobials is not well-documented.

The Study and Its Findings

• The researchers attempted to determine whether administering FMT simultaneously with metronidazole could inhibit the onset of dysbiosis in horses.
• They monitored changes in the ratios of bacterial families using metagenomic analysis, focusing primarily on the Clostridiaceae, Ruminococcaceae, and Enterobacteriaceae families.
• The results revealed that changes in fecal bacterial compositions were primarily caused by the administration of metronidazole, and not influenced by the simultaneous FMT to a statistically significant extent.
• In other words, the simultaneous FMT was unable to prevent metronidazole-induced dysbiosis. The protocol involved using 500 g of donor feces in a 1 L suspension, administered once a day.

Conclusion and Implications

• The study concludes that the current FMT protocol fails to effectively prevent metronidazole-induced gut dysbiosis in horses. As such, it suggests the need for further research and improvements to the FMT procedure.
• This finding is significant as it underscores the potential limitations of FMT as a prophylactic—or preventive—measure against dysbiosis caused by antimicrobial medication. More robust and effective approaches are required to safeguard the gut health of horses undergoing treatment with these medications.